Composite
76%
Novelty
55%
Feasibility
75%
Impact
88%
Mechanistic
94%
Druggability
Safety
Confidence
60%

Mechanistic description

Loss of nuclear TDP-43 in ALS motor neurons first manifests as aberrant inclusion of the STMN2 cryptic exon 2a, producing a truncated non-functional STMN2 protein that impairs microtubule repair at the axon. This splicing defect precedes detectable cytoplasmic TDP-43 aggregation by at least 48h in iPSC motor neurons subjected to TDP-43 depletion, establishing STMN2 cryptic exon inclusion as the earliest measurable loss-of-function event. Restoring STMN2 function with antisense oligonucleotides should delay axonal degeneration even when cytoplasmic aggregates have already formed.

Evidence for (5)

  • [Amyotrophic lateral sclerosis (ALS) - diagnosis, course of disease and treatment options].

    PMID:34879411 2021 Dtsch Med Wochenschr
  • ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair.

    PMID:30643292 2019 Nat Neurosci
  • The genetics of amyotrophic lateral sclerosis.

    PMID:38967083 2024 Curr Opin Neurol
  • Mechanism of STMN2 cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies.

    PMID:36927019 2023 Science
  • TDP-43 Pathology in Alzheimer's Disease.

    PMID:34930382 2021 Mol Neurodegener

Evidence against (2)